Loading organizations...
Loading organizations...
Small molecule-based platform for bone growth and pain reduction.
ZetaGen Therapeutics has raised $22.7M across 2 funding rounds.
ZetaGen Therapeutics has raised $22.7M in total across 2 funding rounds.
ZetaGen Therapeutics has raised $22.7M in total across 2 funding rounds.
ZetaGen Therapeutics's investors include JSTAR Capital Investments, New York Ventures.
ZetaGen Therapeutics has raised $22.7M across 2 funding rounds. Most recently, it raised $12.9M Series B in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 25, 2025 | $12.9M Series B | JSTAR Capital Investments | |
| Aug 11, 2023 | $9.8M Series B | New York Ventures |